What’s ZEALAND PHARMA A/S ORDINARY SHARES DENM (OTCMKTS:ZLDPF) Upside After This Short Interest Decrease?

March 16, 2018 - By Peter Erickson

The stock of ZEALAND PHARMA A/S ORDINARY SHARES DENM (OTCMKTS:ZLDPF) registered a decrease of 9.17% in short interest. ZLDPF’s total short interest was 59,400 shares in March as published by FINRA. Its down 9.17% from 65,400 shares, reported previously. With 100 shares average volume, it will take short sellers 594 days to cover their ZLDPF’s short positions. The short interest to ZEALAND PHARMA A/S ORDINARY SHARES DENM’s float is 0.26%.

It closed at $15.68 lastly. It is down 0.00% since March 16, 2017 and is . It has underperformed by 16.70% the S&P500.

Zealand Pharma A/S, a biotech company, engages in the discovery, design, and development of novel peptide medicines in Denmark. The company has market cap of $477.98 million. The firm markets Lixisenatide, a once-daily prandial GLP-1 peptide receptor agonist for the treatment of type 2 diabetes under the Adlyxin and Lyxumia names; and Soliqua 100/33/Suliqua, a combination of lixisenatide and insulin glargine, and a GLP-1 receptor agonist for the treatment of type 2 diabetes. It currently has negative earnings. The Company’s products under development include Glepaglutide, a novel GLP-2 analogue in Phase II clinical trials for the treatment of short bowel syndrome; Dasiglucagon, a ready-to-use hypo-pen in Phase II clinical trials to treat acute, severe hypoglycemia, as well as in Phase IIa clinical trials for pump diabetes management; Elsiglutide, a novel GLP-2 analogue in Phase II clinical trials to treat chemotherapy-induced diarrhea; and GLP1-GLU, a preclinical stage product for obesity/type 2 diabetes.

More notable recent Zealand Pharma A/S (OTCMKTS:ZLDPF) news were published by: Streetinsider.com which released: “Goldman Sachs Starts Zealand Pharma A/S (ZEAL) at Buy” on September 27, 2017, also Globenewswire.com with their article: “Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12 …” published on March 05, 2018, Globenewswire.com published: “Zealand Pharma to present at Morgan Stanley Global Healthcare Conference in …” on September 05, 2017. More interesting news about Zealand Pharma A/S (OTCMKTS:ZLDPF) were released by: Globenewswire.com and their article: “Zealand Pharma and UniQuest collaborate to develop novel drug candidates for …” published on February 20, 2018 as well as Globenewswire.com‘s news article titled: “Zealand Pharma 2017 full-year results in line with guidance – considerable …” with publication date: March 07, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.